Long-term efficacy of neural circuit blockade for treating blepharospasm: a retrospective case series study - Takeaways - MDSpire

Long-term efficacy of neural circuit blockade for treating blepharospasm: a retrospective case series study

  • By

  • Gang Liu

  • Qiangying Guo

  • Jie Xiang

  • Zhen Xu

  • Suying Chen

  • Yanling Xue

  • Zhitao Liu

  • Huixia Jin

  • Shangyi Yu

  • Ting Jiao

  • Xia Chen

  • Zhenzhen Liu

  • Xiangying Xi

  • Yanhong Li

  • Lili Shang

  • Jiao Du

  • Xianzhong Liu

  • Shihui Wei

  • June 24, 2026

  • 0 min

Share

  • 1

    Neural circuit blockade (NCB) was developed as a novel approach to treat blepharospasm, addressing the lack of effective treatments.

  • 2

    A retrospective analysis of 570 patients showed that NCB significantly improved blepharospasm symptoms over a median follow-up of 51 months.

  • 3

    Postoperative results indicated that 87.5% of patients achieved complete remission, with significant improvements in various grading scales.

  • 4

    NCB operates by reducing trigeminal nerve stimulation, thereby alleviating muscle tension without causing severe complications.

  • 5

    The study adhered to ethical guidelines and included patients who were refractory to other treatments, ensuring data authenticity.

Original Source(s)

Related Content